KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bausch Health Companies (BHC) Finished Goods (2016 - 2018)

Bausch Health Companies' Finished Goods history spans 7 years, with the latest figure at $564.0 million for Q4 2018.

  • On a quarterly basis, Finished Goods fell 9.9% to $564.0 million in Q4 2018 year-over-year; TTM through Dec 2018 was $564.0 million, a 9.9% decrease, with the full-year FY2018 number at $564.0 million, down 9.9% from a year prior.
  • Finished Goods hit $564.0 million in Q4 2018 for Bausch Health Companies, down from $584.0 million in the prior quarter.
  • Over the last five years, Finished Goods for BHC hit a ceiling of $843.0 million in Q2 2015 and a floor of $564.0 million in Q4 2018.
  • Historically, Finished Goods has averaged $658.1 million across 5 years, with a median of $618.0 million in 2018.
  • Biggest five-year swings in Finished Goods: soared 34.96% in 2015 and later dropped 16.56% in 2016.
  • Tracing BHC's Finished Goods over 5 years: stood at $603.9 million in 2014, then soared by 34.96% to $815.0 million in 2015, then fell by 16.56% to $680.0 million in 2016, then dropped by 7.94% to $626.0 million in 2017, then dropped by 9.9% to $564.0 million in 2018.
  • Business Quant data shows Finished Goods for BHC at $564.0 million in Q4 2018, $584.0 million in Q3 2018, and $589.0 million in Q2 2018.